Reevaluating antiviral thresholds in HBV DNA-negative inactive HBsAg carriers: a multicenter histopathological analysis. [PDF]
Ren S +12 more
europepmc +1 more source
Factors associated with persistent positive in HBV DNA level in patients with chronic Hepatitis B receiving entecavir treatment. [PDF]
Li J +18 more
europepmc +1 more source
Recent Developments in HIV Antivirals: The Prospect of Prophylactic Drugs to Change the Pandemic
Replication cycle of HIV‐1. The scheme provides an overview from virus entry over reverse transcription of viral RNA into viral DNA, provirus DNA integration into the host genome, genome expression by transcription and translation, proteolytic processing of the viral polyproteins, viral maturation to viral release from the cell. The various targets for
Harald Brüssow
wiley +1 more source
Characterization of genetic mutations in hepatitis B virus isolated from HBsAg+/HBcAb+/HBsAb-/HBV DNA + Japanese blood donors. [PDF]
Sedohara A +7 more
europepmc +1 more source
MSC‐derived exosomes deliver lnc‐AGT‐3 to vascular endothelial cells, where it binds hnRNP K in the nucleus. This interaction inhibits p53 ubiquitination, enhancing p53 stabilization and transcriptional activation of anti‐angiogenic targets TSP1. Consequently, p53‐mediated signaling is potentiated, effectively suppressing choroidal neovascularization ...
Lingjie Kong +9 more
wiley +1 more source
The blocking efficacy and safety of tenofovir disoproxil fumarate tablets on mother-to-child transmission in pregnant women with high serum HBV DNA load: a retrospective cohort study. [PDF]
Wei Q +7 more
europepmc +1 more source
High HBV-DNA serum levels are associated with type 2 diabetes in adults with positive HBsAg: An observational study. [PDF]
Zhang S, Zong Y, Hu Y, Sheng Y, Xiao G.
europepmc +1 more source
This study evaluated the performance of the PAGE‐B score in HCC risk among CHB patients with metabolic dysfunction or MASLD. The PAGE‐B score effectively stratified HCC risk in both MASLD and non‐MASLD patients, especially in those without cirrhosis, where low scores were linked to negligible 5‐year HCC risk. ABSTRACT Introduction Metabolic dysfunction
Lesley A. Patmore +22 more
wiley +1 more source
Profiles of HBV DNA integration in humans with hepatitis B virus infection: Insights for antiviral treatment. [PDF]
Hui RW +7 more
europepmc +1 more source

